LPAR1 and breast carcinoma: Transgenic mice over-expressing LPA2 developed mammary tumours with the onset and frequency similar to those observed in LPA1 transgenic mice (Liu et al, 2009), further implicating LPA2 in the initiation and progression of breast cancer.